Leiden University Medical Center — Biomedical Watch V2

Traitements9programmes

Essais4liés

Publications0liées

SourceDBlocale

Traitements

9

Molécule	Indication / population	Phase	Objectif	Pays	Résultat
Amifampridine (base) with modified releaseA randomized, double-blind, placebo controlled, crossover intervention study evaluating the effect of pyridostigmine (part 1) and amifampridine (part 2) in Myasthenia Gravis (MG).	Myasthénie	Phase 3	À vérifier	Netherlands	À vérifier
Belimumab InjectionIn follow-up of the previous SynBioSe Study the present study is a randomized controlled trial designed to further investigate the long-term clinical and imunological efficacy of combination B-cell targeting by starting treatment with belimumab (anti-BAFF) followed by rituximab(anti-CD20) in lupus nephritis patients.	Lupus	Phase 3	Immunomodulation	Netherlands	À vérifier
CAPTURE - MG — Capturing Key MG-symptoms Using Smartphone Recordings.This study will make use of a cross-sectional design of MG patients and non-MG participants to quantitatively assess key MG symptoms, and to explore the applicability of machine learning algorithms to their measurement.	Myasthénie	À vérifier	Traitement symptomatique	Netherlands	À vérifier
FIT to ACT-MG — Interventions Against Fatigue in Patients With Myasthenia GravisA prospective assessor-blinded randomized clinical trial investigating the effect of aerobic exercise therapy or cognitive behavioural therapy on fatigue in patients with myasthenia gravis.	Myasthénie	Non applicable	Traitement symptomatique	Netherlands	À vérifier
PyridostigmineA randomized, double-blind, placebo controlled, crossover intervention study evaluating the effect of pyridostigmine (part 1) and amifampridine (part 2) in Myasthenia Gravis (MG).	Myasthénie	Phase 3	À vérifier	Netherlands	À vérifier
PyridostigmineA randomized, double-blind, placebo controlled, crossover intervention study evaluating the effect of pyridostigmine (part 1) and amifampridine (part 2) in Myasthenia Gravis (MG).	Myasthénie	Phase 3	À vérifier	Netherlands	À vérifier
FIT to ACT-MG — Interventions Against Fatigue in Patients With Myasthenia GravisA prospective assessor-blinded randomized clinical trial investigating the effect of aerobic exercise therapy or cognitive behavioural therapy on fatigue in patients with myasthenia gravis.	Myasthénie	Non applicable	Traitement symptomatique	Netherlands	À vérifier
CAPTURE - MG — Capturing Key MG-symptoms Using Smartphone Recordings.This study will make use of a cross-sectional design of MG patients and non-MG participants to quantitatively assess key MG symptoms, and to explore the applicability of machine learning algorithms to their measurement.	Myasthénie	À vérifier	Traitement symptomatique	Netherlands	À vérifier
Belimumab InjectionIn follow-up of the previous SynBioSe Study the present study is a randomized controlled trial designed to further investigate the long-term clinical and imunological efficacy of combination B-cell targeting by starting treatment with belimumab (anti-BAFF) followed by rituximab(anti-CD20) in lupus nephritis patients.	Lupus	Phase 3	Immunomodulation	Netherlands	À vérifier

Essais cliniques

4

Molécule	Indication / population	Phase	NCT	Titre	Statut
Belimumab Injection	Lupus	Phase 3	NCT03747159	SynBioSe-2 — Synergetic B-cell Immunomodulation in SLE - 2nd Study.	COMPLETED
CAPTURE - MG — Capturing Key MG-symptoms Using Smartphone Recordings.	Myasthénie	À vérifier	NCT06743490	CAPTURE - MG — Capturing Key MG-symptoms Using Smartphone Recordings.	RECRUITING
FIT to ACT-MG — Interventions Against Fatigue in Patients With Myasthenia Gravis	Myasthénie	Non applicable	NCT06659627	FIT to ACT-MG — Interventions Against Fatigue in Patients With Myasthenia Gravis	ACTIVE_NOT_RECRUITING
Pyridostigmine	Myasthénie	Phase 3	NCT05919407	IMPACT-MG — Pyridostigmine and Amifampridine for Myasthenia Gravis	UNKNOWN

Publications

0

Molécule	Indication / population	Titre	Journal	Date
Aucune publication.